AbbVie competitors

AbbVie's competitors include MyoKardia, GlaxoSmithKline, Novartis, Roche and Johnson & Johnson

Add company...

Save Comparison Clear all	AbbVie AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.	MyoKardia MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.	GlaxoSmithKline GlaxoSmithKline is a science-led healthcare company.	Novartis Novartis provides healthcare solutions that address the evolving needs of patients and societies.	Roche Roche Holding is a diagnostics and pharmaceutical company.	Johnson & Johnson Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Founding Date	Founding Date 2013	Founding Date 2012	Founding Date 2000	Founding Date 1996	Founding Date 1896	Founding Date 1886
Type	Type Public	Type Public	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare drug development healthtech pharma scientific research	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development manufacturer pharma	Tags Healthcare biotech clinical research drug development manufacturer pharma	Tags Healthcare Manufacturing & Industrial conglomerates consumer chemistry consumer goods health & beauty manufacturer medical devices pharma
Locations	Locations North Chicago, US HQ Ludwigshafen, DE Sligo, IE Cork, IE Campoverde, IT Tokyo, JP Jayuya, PR see more	Locations South San Francisco, US HQ	Locations Brentford, GB HQ	Locations Basel, CH HQ Beijing, CN Wehr, DE Tokyo, JP New York, US East Hanover, US	Locations Basel, CH HQ South San Francisco, US	Locations New Brunswick, US HQ Dhaka, BD Machelen, BE Suzhou, CN New Delhi, IN see more
Employees	Employees 29,000	Employees 1024% increase	Employees 98,462	Employees 126,0004% increase	Employees 93,734	Employees 134,000
Valuation ($)	Valuation ($) 148.7 b	Valuation ($) 2.3 b	Valuation ($) 101.9 b	Valuation ($) 175.5 b	Valuation ($) N/A	Valuation ($) 355.4 b
Facebook likes	Facebook likes 11.9 k	Facebook likes N/A	Facebook likes 273 k	Facebook likes 304.3 k	Facebook likes 80.2 k	Facebook likes 776.4 k
Twitter followers	Twitter followers 48.3 k	Twitter followers 387	Twitter followers 163.4 k	Twitter followers 234.4 k	Twitter followers 177.2 k	Twitter followers 90.5 k
Financial ⚠
Revenue (est.)	Revenue (est.) $25.6b (FY, 2016)	Revenue (est.) $22.5m (FY, 2017)	Revenue (est.) £30.2b (FY, 2017)	Revenue (est.) $48.5b (FY, 2016)	Revenue (est.) CHF48.1b (FY, 2015)	Revenue (est.) $76.5b (FY, 2017)
Cost of goods	Cost of goods $5.8b (FY, 2016)	Cost of goods N/A	Cost of goods £10.3b (FY, 2017)	Cost of goods $17.5b (FY, 2016)	Cost of goods CHF15.5b (FY, 2015)	Cost of goods $25.4b (FY, 2017)
Gross profit	Gross profit $19.8b (FY, 2016)	Gross profit N/A	Gross profit £19.8b (FY, 2017)	Gross profit $31b (FY, 2016)	Gross profit CHF32.7b (FY, 2015)	Gross profit $51.1b (FY, 2017)
Net income	Net income $6b (FY, 2016)	Net income ($46m) (FY, 2017)	Net income £2.2b (FY, 2017)	Net income $6.7b (FY, 2016)	Net income CHF9.1b (FY, 2015)	Net income $1.3b (FY, 2017)
Operating ⚠
Countries	Countries N/A	Countries N/A	Countries 100 (FY, 2016)	Countries N/A	Countries N/A	Countries 60 (FY, 2017)
Drugs Approved by FDA	Drugs Approved by FDA N/A	Drugs Approved by FDA N/A	Drugs Approved by FDA N/A	Drugs Approved by FDA N/A	Drugs Approved by FDA 2 (Y, 2015)	Drugs Approved by FDA 2 (FY, 2015)
Major Approvals (US, EU, JP)	Major Approvals (US, EU, JP) N/A	Major Approvals (US, EU, JP) N/A	Major Approvals (US, EU, JP) N/A	Major Approvals (US, EU, JP) 16 (Y, 2016)	Major Approvals (US, EU, JP) 12 (Y, 2016)	Major Approvals (US, EU, JP) N/A
Manufacturing Facilities	Manufacturing Facilities N/A	Manufacturing Facilities N/A	Manufacturing Facilities 87 (FY, 2016)	Manufacturing Facilities N/A	Manufacturing Facilities N/A	Manufacturing Facilities 125 (FY, 2017)
US FDA Breakthrough Therapy Designations	US FDA Breakthrough Therapy Designations N/A	US FDA Breakthrough Therapy Designations N/A	US FDA Breakthrough Therapy Designations N/A	US FDA Breakthrough Therapy Designations 5 (Y, 2016)	US FDA Breakthrough Therapy Designations 5 (Y, 2016)	US FDA Breakthrough Therapy Designations N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 98m	Total funding raised N/A	Total funding raised $ 6.5m	Total funding raised N/A	Total funding raised N/A